Mechanisms and molecular targets surrounding the potential therapeutic effects of psychedelics.
Alaina M JasterJavier González-MaesoPublished in: Molecular psychiatry (2023)
Psychedelics, also known as classical hallucinogens, have been investigated for decades due to their potential therapeutic effects in the treatment of neuropsychiatric and substance use disorders. The results from clinical trials have shown promise for the use of psychedelics to alleviate symptoms of depression and anxiety, as well as to promote substantial decreases in the use of nicotine and alcohol. While these studies provide compelling evidence for the powerful subjective experience and prolonged therapeutic adaptations, the underlying molecular reasons for these robust and clinically meaningful improvements are still poorly understood. Preclinical studies assessing the targets and circuitry of the post-acute effects of classical psychedelics are ongoing. Current literature is split between a serotonin 5-HT 2A receptor (5-HT 2A R)-dependent or -independent signaling pathway, as researchers are attempting to harness the mechanisms behind the sustained post-acute therapeutically relevant effects. A combination of molecular, behavioral, and genetic techniques in neuropharmacology has begun to show promise for elucidating these mechanisms. As the field progresses, increasing evidence points towards the importance of the subjective experience induced by psychedelic-assisted therapy, but without further cross validation between clinical and preclinical research, the why behind the experience and its translational validity may be lost.
Keyphrases
- liver failure
- clinical trial
- signaling pathway
- respiratory failure
- systematic review
- cell therapy
- drug induced
- single molecule
- big data
- randomized controlled trial
- intensive care unit
- gene expression
- copy number
- stem cells
- climate change
- cell proliferation
- oxidative stress
- physical activity
- pi k akt
- bone marrow
- induced apoptosis
- mass spectrometry
- mechanical ventilation
- open label